4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-027086
Chief Executive Officer sold 14,683 shares at $246.26 ($3,615,821)
- Chief Executive Officer gave up 8,781.14 shares (to pay taxes)
- Chief Executive Officer acquired 14,683 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,683 | $84.98 | $1,247,761 | 478,937 | D |
| 2024-11-07 | Sale : show line 2 in the form 10b5-1 | −14,683 | $246.26 | $3,615,821 | 464,254 | D |
| 2024-11-11 | Shares withheld for taxes : show line 3 in the form 10b5-1 | −3,101.38 | $252.38 | $782,725 | 461,152 | D |
| 2024-11-11 | Shares withheld for taxes : show line 4 in the form 10b5-1 | −2,226.86 | $252.38 | $562,016 | 458,925 | D |
| 2024-11-11 | Shares withheld for taxes : show line 5 in the form 10b5-1 | −3,452.9 | $252.38 | $871,443 | 455,472 | D |
| Open-market sales · 14,683 sh · avg $246.26 · $3,615,821 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-07 | Exercise or conversion : show line 6 in the form 10b5-1 ResMed Common Stock Options | −14,683 | 0 | D |
Loading xslF345X05/form4.xml…